People · Operator
Named in public records as an officer, director or promoter · active 2013–2015 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oberon FMR, Inc. | — | Other | Series A | $24.0M | $85.0M | 2013 |
| Nutraceutical Innovations, Inc. | — | Other | Pre-Seed | $125K | $2.9M | 2013 |
Leo Gingras at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Leo Gingras on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Calvin Kidd | 1 | 10 |
| Calvin Goforth | 1 | 10 |
| Tim Wilson | 1 | 7 |
| Mark Lupa | 1 | 5 |
| Mark J. Lupa | 1 | 2 |
| David Tze | 1 | 2 |
| Gary Bridge | 1 | 1 |
| Jisheng Song | 1 | 1 |
| Seth Terry | 1 | 1 |
| Andrew Logan | 1 | 1 |
| Jingbo Wang | 1 | 1 |
| Randolphe P. Swenson, Jr. | 1 | 1 |
| David J. Tze | 1 | 1 |
| Navam Hettiarachchy | 1 | 1 |
| Collis Geren | 1 | 1 |
| James J Gregory | 1 | 1 |
| Seth S Terry | 1 | 1 |
| Andrew J Logan | 1 | 1 |
| Andrew Baum | 1 | 1 |
| Richard Bond | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.